 Hyperlipidemia organ transplantation Hyperlipidemia difficult common problem organ transplantation underlying cause accelerated atherosclerosis heart transplant recipients children renal transplants addition hyperlipidemia role late renal graft loss cause post-transplant hyperlipidemia unclear patients azathioprine prednisone hypertriglyceridemia commonest finding results consumption calories carbohydrate fat resolution uremia conjunction glucose intolerance secondary administration patients cyclosporine hypercholesterolemia common form hyperlipidemia Cyclosporine lipophilic drug plasma association lipoproteins low-density lipoprotein LDL receptor internalization cells Hypercholesterolemia interference basic cholesterol feedback mechanism LDL receptor addition cyclosporine affects bile acid synthesis worsens glucose tolerance factors hyperlipidemia first therapeutic approach transplant recipient dietary calorie-fat restriction supplementation soluble fiber clinical trials available pharmacologic lipid-lowering agents safety efficacy agents setting immunosuppression time low doses